Opinion
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Holmer_Ariela_K_NY_web.jpg)
Selecting therapies in moderate to severe inflammatory bowel disease: Key factors in decision making
- Author:
- Ariela K. Holmer, MD
- Shannon Chang, MD, MBA
- Lisa Malter, MD
Publish date: November 1, 2023
While efficacy is often considered first when choosing a drug, other critical factors play a role in tailoring a treatment plan.